BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Lagos
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0100
TZNAME:WAT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240208
DTEND;VALUE=DATE:20240209
DTSTAMP:20240201T184853Z
CREATED:20240201T184853Z
LAST-MODIFIED:20240201T184853Z
UID:59785-1707350400-1707436799@globalbiodefense.com
SUMMARY:Enhancing Biotechnology Innovation and Applications for National Security – First Meeting of Experts
DESCRIPTION:The National Academies will convene a meeting of experts on 8 Feb 2024 to focus on ways to foster a research and development network in the United States that drives biotechnology innovation and applications. \nThis meeting will be held in a hybrid setting (Washington DC and online). \nThis is the first of a series of meetings of experts\, organized under the auspices of the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology\, which will bring together gatherings of cross-sector experts to discuss key topics at the intersection of national security and transdisciplinary biotechnology research and development. \nThe forthcoming second meeting of experts will focus on understanding future defense needs and ways to communicate those needs to the research community.  The third meeting of experts will focus on understanding the regulatory processes and needs in the United States to enhance development of innovative biotechnologies for defense and subsequently\, to transition defense-specific biotechnologies and services to other sectors. \nEach meeting will highlight how more general concepts relate to specific biotechnologies using two illustrative examples: \n\nUse of artificial intelligence in biotechnology research and development\nExperimental/laboratory automation in biotechnology and development\n\nThe effort is sponsored by the National Security Commission on Emerging Biotechnology. \nPlease visit the  Enhancing Biotechnology Innovation and Applications for National Security – First Meeting of Experts.
URL:https://globalbiodefense.com/event/enhancing-biotechnology-innovation-and-applications-for-national-security-first-meeting-of-experts/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T080000
DTEND;TZID=America/New_York:20240208T170000
DTSTAMP:20240201T220044Z
CREATED:20240201T215837Z
LAST-MODIFIED:20240201T220044Z
UID:59814-1707379200-1707411600@globalbiodefense.com
SUMMARY:Why Indoor Chemistry Matters Prioritizing Indoor Chemistry Research - Workshop 2
DESCRIPTION:A National Academies committee of experts on Emerging Science on Indoor Chemistry will meet for a workshop on 8 February 2024 to discuss ways to support and prioritize indoor chemistry research. \nThe event is a hybrid in-person (Washington DC) and virtual format. \nThis event aims to discuss the following topics: \n\nOutcomes and recommendations from the National Academies consensus report Why Indoor Chemistry Matters.Special focus will be given to Recommendation 8 “ Given the challenges\, complexity\, knowledge gaps\, and importance of indoor chemistry\, federal agencies and others that fund research should make the study of indoor chemistry and its impact on indoor air quality and public health a national priority”.\nEmerging or impactful areas of indoor chemistry research.\nExamine current funding opportunities available for indoor chemistry research; identify how sustained support for the field can be achieved in the near future.\nA major goal on this workshop is to encourage more partnerships with funding agencies\, foundations\, and NGOs to strengthen investment in indoor chemistry research.\n\nHighlighted agenda topics include: \nWhy Indoor Chemistry Matters: Select Recommendations \n\nVicki H. Grassian\, PhD\, Chair\, Department of Chemistry and Biochemistry\, University of California\, San Diego\n\nAssessing Chemical Complexity in Indoor Environments \n\nJonathan Abbatt\, PhD\, Professor\, University of Toronto\nRobin E. Dodson\, ScD\, Associate Director of Research Operations and Research Scientist\, Silent Spring Institute\nVito Ilacqua\, PhD\, Acting Director of the Center for Scientific Analysis\, Office of Radiation and Indoor Air (ORIA)-Office of Air and Radiation (OAR)\, U.S. Environmental Protection Agency\nXiaoyu Liu\, PhD\, Senior Physical Scientist\, U.S. Environmental Protection Agency\nBarbara Turpin\, PhD\, Professor\, University of North Carolina\, Chapel Hill\n\nGermicidal UV Radiation\, Unintended Chemistry: \n\nDelphine Farmer\, PhD\, Professor\, Colorado State University\nMichael F. Link\, Physical Scientist\, Engineering Laboratory\, National Institute of Standards and Technology (NIST)\nPaula Olsiewski\, PhD\, Contributing Scholar\, Johns Hopkins Center for Health Security\nRichard Williamson\, Program Director\, Far-UVC\, Blueprint Biosecurity\n\nHow Do we Strengthen the Handshake Between IAQ and Exposure Science/Cognition\, Health and Well-Being: \n\nAntonia Calafat\, PhD\, Chief\, Organic Analytical Toxicology Branch\, Centers for Disease Control and Prevention\nElaine Cohen-Hubal\, PhD\, Senior Science Advisor\, U.S. Environmental Protection Agency\nLCDR Jason Ham\, PhD\, Research Scientist\, Health Effects Laboratory Division (HELD)\, Chemical and Biological Monitoring Branch (CBMB)\, National Institute for Occupational Safety and Health (NIOSH)\nKrystal Pollitt\, PhD\, PEng\, Associate Professor of Epidemiology\, Yale School of Public Health (YSPH)\nTreye Thomas\, PhD\, Lead Toxicologist and Program Manager\, Chemicals\, Nanotechnology and Emerging Materials (CNEM) Program\, Office of Hazard Identification and Reduction\, Consumer Product Safety Commision (CPSC\n\nBuildings Impact on Chemistry \n\nMark Hernandez\, PhD\, Professor\, University of Colorado\, Boulder\nJeffrey Siegel\, PhD\, Professor\, University of Toronto\nBrett Singer\, PhD\, Staff Scientist and Principal Investigator (PI)\, Energy Technologies Area\, Lawrence Berkeley National Laboratory\nDavid Rowson\, Director Indoor Environments Division\, Environmental Protection Agency\nBrian Gilligan\, PEng\, SCPM \, Deputy Director\, Office of Federal High Performance Green Buildings\, General Services Administration\n\nRESOURCES: \nWhy Indoor Chemistry Matters (2022) \nPeople spend the vast majority of their time inside their homes and other indoor environments where they are exposed to a wide range of chemicals from building materials\, furnishings\, occupants\, cooking\, consumer products\, and other sources. Despite research to date\, very little is known about how exposures to indoor chemicals across complex chemical phases and pathways affect human health. The COVID-19 pandemic has only increased public awareness of indoor environments and shed light on the many outstanding questions about how best to manage chemicals indoors. \nPROJECT GOALS: \nThis study will examine the state of science regarding chemicals in indoor air. A team of scientific experts will focus on under-reported chemical science discoveries and how these findings shine light on the link between chemical exposure\, air quality\, and human health. The final report will explore potential opportunities for new scientific research. It will also identify what research will be most critical to understanding the chemical composition of indoor air and adverse exposures. The environments in this study will be limited to non-industrial exposure within buildings. \nPlease visit the Why Indoor Chemistry Matters Workshop 2: Prioritizing Indoor Chemistry Research event page to register.
URL:https://globalbiodefense.com/event/why-indoor-chemistry-matters-prioritizing-indoor-chemistry-research-workshop-2/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T110000
DTEND;TZID=America/New_York:20240215T160000
DTSTAMP:20240202T000503Z
CREATED:20240202T000503Z
LAST-MODIFIED:20240202T000503Z
UID:59822-1707994800-1708012800@globalbiodefense.com
SUMMARY:Forum on Medical and Public Health Preparedness for Disasters and Emergencies
DESCRIPTION:The Forum on Medical and Public Health Preparedness for Disasters and Emergencies will convene again on 15 February 2024. \nIn this meeting\, Forum members will: \n\nIdentify the seminal social and behavioral sciences (SBS) lessons learned from COVID-19 and other past public health emergencies\nExplore how SBS lessons\, concepts\, and theories can be leveraged to inform and be incorporated in future medical and public health preparedness and response efforts\nDiscuss receive updates\, and provide input on current and planned Forum activities and other National Academies activities of interest.\n\nFormed in 2007\, the Forum on Medical and Public Health Preparedness for Disasters and Emergencies convenes and engages leaders at federal\, state\, local\, tribal\, and territorial levels representing government\, non-profit\, and for-profit sectors to improve the nation’s medical and public health preparedness for\, response to\, and recovery from disasters and emergencies\, including emerging threats. \nRecent work of the Forum includes: \n\nMedical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships\nFuture of the Nation’s Laboratory Systems for Health Emergency Response\n Future Planning for the Public Health Emergency Preparedness Enterprise: Lessons Learned from the COVID-19 Pandemic\nApplying Lessons Learned from COVID-19 Research and Development to Future Epidemics\nAccelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance\nEvolving Crisis Standards of Care and Lessons Learned\nCOVID-19: Disaster Preparedness and Vulnerable Populations\nEnhancing Private Sector Readiness for 21st Century Health Threats\nEngaging Private Sector Healthcare Systems in Building Capacity to Respond to Threats to the Public’s Health and National Security\nThe Future of Disaster Health Volunteerism\n\nPlease visit the National Academies’ Forum on Medical and Public Health Preparedness for Disasters and Emergencies – February 2024 Meeting  website for more information. \n 
URL:https://globalbiodefense.com/event/forum-on-medical-and-public-health-preparedness-for-disasters-and-emergencies/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T120000
DTEND;TZID=America/New_York:20240215T130000
DTSTAMP:20240125T224115Z
CREATED:20240125T223922Z
LAST-MODIFIED:20240125T224115Z
UID:59701-1707998400-1708002000@globalbiodefense.com
SUMMARY:The Clear and Present Threat of Chem-Bio and Data and Cyberscientific and Technological (CB-DCST) Tools and Techniques
DESCRIPTION:The Homeland Defense & Security Information Analysis Center (HDIAC) will host a webinar on The Clear and Present Threat of Chem-Bio and Data and Cyberscientific and Technological (CB-DCST) Tools and Techniques on 15 February 2024. \nGiven the current global shift toward symmetrical warfare\, major powers and nonstate proxies are developing radical leveling and emerging technology for use as “deterrence leveraging” in nonkinetic and kinetic engagements. \nAlthough regnant treaties and conventions are postured to govern chemical and biological weapons\, novel advances in genetics\, synthetic biology\, and neuroscience can enable side-stepping such international regulatory constraints when coupled with big data and cyberscientific tools and methods. These advances can also afford rapid scientific and technological progress in ways that pose a clear and present threat to global biosecurity and defense. \nIn this webinar\, Dr. James Giordano will present an overview of current and emerging developments in CB-DCST; describe trajectories for their deterrent applications in nonkinetic and/or kinetic engagements; address ethico-legal issues relevant to their research\, use\, and governance; and propose a paradigm for realistic approach to informing surveillance\, forecasting\, and regulatory control. \nABOUT THE SPEAKER : Dr. James Giordano\, Ph.D.\, MPhil \nDr. James Giordano is Pellegrino Center professor of neurology and biochemistry\, chief of the Neuroethics Studies Program\, and codirector of the Project on Brain Science and Global Health Law and Policy at Georgetown University Medical Center. He serves as senior bioethicist of the Defense Medical Ethics Center\, Uniformed Services University of Health Sciences; Stockdale distinguished fellow of science\, technology\, and ethics at the U.S. Naval Academy; and non-resident senior fellow of the Simon Center for the Professional Military Ethic at the U.S. Military Academy\, West Point\, NY. \nPlease visit HDIAC’s The Clear and Present Threat of Chem-Bio and Data and Cyberscientific and Technological (CB-DCST) Tools and Techniques on 15 February 2024.
URL:https://globalbiodefense.com/event/the-clear-and-present-threat-of-chem-bio-and-data-and-cyberscientific-and-technological-cb-dcst-tools-and-techniques/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240220
DTEND;VALUE=DATE:20240222
DTSTAMP:20240207T184247Z
CREATED:20240207T184123Z
LAST-MODIFIED:20240207T184247Z
UID:59952-1708387200-1708559999@globalbiodefense.com
SUMMARY:CWMD/MCDC Winter Medical & WMD Countermeasure Symposium
DESCRIPTION:The CWMD/MCDC: 2024 Winter Medical & WMD Countermeasure Symposium will be held 20-21 February 2024 in Baltimore\, Maryland. \nHosted by the Countering Weapons of Mass Destruction Consortium (CWMD) and the Medical CBRN Defense Consortium (MCDC)\, the event will feature sessions to interact with leads from key programs\, for example: \n\nJPEO Futures\nJoint Project Leads (JPL) PL Enabling Biotechnologies (EB)\nJoint Project Managers (JPM) Special Operations Forces (SOF)\nJoint Project Managers (JPM) Protection\n\nPoster Registration Deadline is 14 February. \nABOUT THE CWMD CONSORTIUM \nThe Countering Weapons of Mass Destruction (CWMD) Consortium is a well-established community of industry\, academia and government focused on rapid prototyping and maturing countering WMD efforts and CBRNE hazard awareness. Through an Other Transaction Agreement with the JPEO-CBRND (Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense)\, the CWMD Consortium is accomplishing the counter WMD related prototyping needs of any federal agency. \nThe CWMD scope spans development of PPE\, detection systems\, sensors\, other protection needs\, and situational awareness. These address consequence management/hazard mitigation; threats/vulnerabilities awareness and counter-proliferation technologies/capabilities; arms control technologies; experimentation of emerging technologies and CBRNE technologies to deliver capabilities to the warfighter. \nABOUT THE MEDICAL CBRN DEFENSE CONSORTIUM \nThe Medical CBRN Defense Consortium (MCDC) is a well-established community of industry\, academia\, and government focused on rapid prototyping and maturing medical countermeasures to prevent\, detect and treat exposure to CBRN threats. Through an Other Transaction Agreement with the JPEO-CBRND (Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense)\, the MCDC is developing life-saving medical pharmaceutical\, diagnostics and therapeutics to safe-guard and enhance the mission effectiveness of our soldiers. \nThe MCDC scope spans development of medical countermeasure prototypes to include vaccines (COVID-19\, Marburg\, Ebola\, VEE\, VEEV\, Botulinum\, etc.)\, therapeutics (COVID-19\, SNAPP\, small molecule antivirals\, OPNAs\, Smallpox\, MDR Bacterial bio threat pathogens\, Tularemia\, etc.)\, detection/diagnostics (Meliodiosis\, Plague\, CRISPR-based\, man-portable diagnostics systems\, antibody platforms\, etc.)\, autoinjectors (Scopolamine\, Naloxone\, Diazepam\, etc.) and other needs. \nPlease visit the Medical CBRN Defense Consortium site for more information or register here for the CWMD/MCDC Winter Medical & WMD Countermeasure Symposium.
URL:https://globalbiodefense.com/event/cwmd-mcdc-winter-medical-wmd-countermeasure-symposium/
LOCATION:Baltimore Marriott Waterfront\, 700 Aliceanna St\, Baltimore\, MD\, 21202\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240220
DTEND;VALUE=DATE:20240228
DTSTAMP:20240219T192805Z
CREATED:20240202T233915Z
LAST-MODIFIED:20240219T192805Z
UID:59870-1708387200-1709078399@globalbiodefense.com
SUMMARY:The 38th Annual AAAI Conference on Artificial Intelligence
DESCRIPTION:The AAAI-24 Annual Conference on Artificial Intelligence will be held 20-27 February in Vancouver\, Canada. \nThe purpose of the AAAI conference series is to promote research in Artificial Intelligence (AI) and foster scientific exchange between researchers\, practitioners\, scientists\, students\, and engineers across the entirety of AI and its affiliated disciplines. AAAI-24 will feature technical paper presentations\, special tracks\, invited speakers\, workshops\, tutorials\, poster sessions\, senior member presentations\, competitions\, and exhibit programs\, and a range of other activities to be announced. \nHighlighted topics and presentations include: \n\nML+Optimization: Driving Social Impact in Public Health and Conservation\nDeploying ADVISER : Impact and Lessons from using Artificial Intelligence for Child Vaccination Uptake in Nigeria\nOutlier Ranking for Large-Scale Public Health Data\nGeometric ML: from Euclid to Drug Design\nGenerating Novel Leads for Drug Discovery Using LLMs with Logical Feedback\nAngle Robustness Unmanned Aerial Vehicle Navigation in GNSS-Denied Scenarios\nGeometric-Facilitated Denoising Diffusion Model for 3D Molecule Generation\nProtein 3D Graph Structure Learning for Robust Structure-Based Protein Property Prediction\nDual-Channel Learning Framework for Drug-Drug Interaction Prediction via Relation-Aware Heterogeneous Graph Transformer\nGxVAEs: Two Joint VAEs Generate Hit Molecules from Gene Expression Profile\nPSC-CPI: Multi-Scale Protein Sequence-Structure Contrasting for Efficient and Generalizable Compound-Protein Interaction Prediction\nA Multi-Modal Contrastive Diffusion Model for Therapeutic Peptide Generation\nRegulating AI: Applying Insights from Behavioural Economics and Psychology to the Application of Article 5 of the EU AI Act\n\nPlease visit the AAAI-24 Conference website for more information and to register.
URL:https://globalbiodefense.com/event/the-38th-annual-aaai-conference-on-artificial-intelligence/
LOCATION:Vancouver Convention Center\, 1055 Canada Pl\, Vancouver\, British Columbia\, V6C 0C3\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20240220T090000
DTEND;TZID=Europe/Zurich:20240220T103000
DTSTAMP:20240219T010614Z
CREATED:20240219T010514Z
LAST-MODIFIED:20240219T010614Z
UID:60060-1708419600-1708425000@globalbiodefense.com
SUMMARY:CIABT and Biological Risks
DESCRIPTION:Advances in biotechnology generate new opportunities\, but also create certain risks in terms of dual use of biological and toxin agents and with respect to compliance with the 1972 Convention on the Prohibition of Biological Weapons (CIABT). \nThis is the first event in a series of French-speaking meetings on disarmament in 2024 which will present the CIABT and provide a more in-depth analysis of contemporary biological risks\, including in relation to artificial intelligence and cyber. The event will also provide insight into the ongoing work of the CIABT Working Group established by the 9th Review Conference in November 2022. \nThe event is open to all interested participants. The United Nations Institute for Disarmament Research (UNIDIR) encourages the participation of French-speaking representatives and experts specialized in or interested in issues related to CIABT and/or biological risks. This event will take place in French. No interpretation into other UN languages ​​will be provided. \nPROGRAMME \n\nWelcome Address: Dr. Robin Geiss \, Director\, UNIDR\nIntroductory remarks : Mr. Guillaume Ollagnier \, Director of Strategic Affairs\, Security and Disarmament at the Ministry of Europe and Foreign Affairs of France\, and HE Camille Petit \, Permanent Representative of France to the Conference on Disarmament\nPresentation of the CIABT : Mr. Remi Bacouillard \, Political Affairs Officer\, CIABT Implementation Support Unit\, Office for Disarmament Affairs (UNODA)\nOverview of scientific and technological advances : Dr. Anna Laura Ross \, Head of the Emerging Technologies Unit of the Division of Science of the World Health Organization (WHO)\, and Ms. Louison Mazeaud \, Associate Researcher\, Weapons Program mass destruction\, UNIDIR\nPerspectives on the ongoing work of the CIABT Working Group : Ms. Barbara Belkior \, Minister-Counsellor\, Permanent Representation of Brazil to the Conference on Disarmament\nConcluding remarks : HE Salomon Eheth\, Permanent Representative of Cameroon to the United Nations Office and other international organizations in Geneva\n\nThe event will be moderated by the Permanent Observer of the International Organization of la Francophonie (OIF) to the United Nations Office in Geneva\, HE Henri Monceau. \nPlease visit the UNIDR website for registration.
URL:https://globalbiodefense.com/event/ciabt-and-biological-risks/
LOCATION:Palais des Nations\, 1211 Geneva 10\, Geneva\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240220T120000
DTEND;TZID=America/Los_Angeles:20240220T130000
DTSTAMP:20240202T212828Z
CREATED:20240202T212828Z
LAST-MODIFIED:20240202T212828Z
UID:59865-1708430400-1708434000@globalbiodefense.com
SUMMARY:Threat-Agnostic Biodefense: Assessing the Zoonotic Risk of Pre-emergent Viruses
DESCRIPTION:The Pacific Northwest National Laboratory will host a webinar on “Assessing the Zoonotic Risk of Pre-emergent Viruses” on 20 February 2024 as part of the the Advancing Threat Agnostic Biodefense Webinar Series. \nThese webinars bring together like-minded science and policy members of the biodefense community to discuss relevant research activities as well as barriers and enablers of a threat agnostic approach. \nFeatured speaker: Tony Goldberg\, PhD\, Professor\, School of Veterinary Medicine\, University of Wisconsin-Madison \nExploration of the “virosphere” is in its golden age. The sheer number of new viruses discovered daily\, and the fact that most cannot be cultured\, creates enormous about where to allocate attention and resources. It is not an intractable problem\, however\, to distinguish those few viruses that are likely to emerge as zoonoses from the many others that are not. \nThis talk describes two diametric approaches to addressing this problem. The first approach involves a field-to-lab investigative methodology that\, when combine with biologically informed predictive computational models\, can assess the zoonotic risk of viruses that have not yet been identified in humans. \nThe second approach relies on the power of modern methods in anthropology and ethnography to identify zoonotic transmission pathways\, even before the identification of any pathogens that might traverse those pathways. A unifying example is simian hemorrhagic fever virus and its relatives in the family Arteriviridae\, which cause important animal diseases but have never been documented to infect humans. Both approaches identify these viruses as high-risk pre-emergent zoonoses. \nPlease visit PNNL for more information and to register.
URL:https://globalbiodefense.com/event/threat-agnostic-biodefense-assessing-the-zoonotic-risk-of-pre-emergent-viruses/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240222T090000
DTEND;TZID=America/New_York:20240222T160000
DTSTAMP:20240202T211124Z
CREATED:20240202T210750Z
LAST-MODIFIED:20240202T211124Z
UID:59861-1708592400-1708617600@globalbiodefense.com
SUMMARY:PACCARB Public Meeting
DESCRIPTION:The 24th Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) public meeting will be held virtually on February 22\, 2024. \nThis will be the second of two meetings to address the task provided to the PACCARB by the Secretary of HHS to address antimicrobial resistance globally. The focus of the meeting will be on international implementers and the gaps\, challenges\, and opportunities they see to combat AMR globally – specifically focusing on low- and middle-income countries. \nMeetings of the PACCARB are open to the public\, and virtual meetings can be accessed through the webcast. Registration to attend is not required but is encouraged. Attendees may also directly address the council on topics of antimicrobial resistance during public meetings. To provide written comments\, please e-mail your comments to CARB@hhs.gov. Written comments must be sent in by midnight February 15\, 2024 and should be limited to no more than one page. All public comments received prior to the deadline will be provided to the PACCARB council members. \nMeeting times are tentative and subject to change. Please visit HHS’ PACCARB website for the most current information.
URL:https://globalbiodefense.com/event/paccarb-public-meeting/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240223
DTEND;VALUE=DATE:20240224
DTSTAMP:20240218T175243Z
CREATED:20240218T174811Z
LAST-MODIFIED:20240218T175243Z
UID:60021-1708646400-1708732799@globalbiodefense.com
SUMMARY:Rapid Access to Products in Development (RAPID) Virtual Industry Day
DESCRIPTION:A Joint Industry Day for the Rapid Access to Products in Development (RAPID) program to be held virtually on 23 Feb 2024. \nThe Joint Program Executive Office for Chemical\, Biological\, Radiological\, and Nuclear Defense\, Enabling Biotechnologies (JPEO-CBRND-EB)\, develops\, manufactures and delivers safe and effective Medical Countermeasures (MCMs) for preparedness\, prevention\, protection\, response\, and recovery from CBRN threats. \nThe Rapid Access to Products in Development (RAPID) program is an integrated defense system composed of both physical MCM storage and fielding capabilities and a readily accessible information warehouse and sharing system (the RAPID Database). \nThe purpose of this Industry Day is to identify industry partners and capabilities to develop a RAPID Database capable of storing and organizing complex data and information related to CBRN MCMs such that it is intuitively accessible by a variety of end users during urgent planning and response situations. \nThe Database is intended to provide actionable information to assist CCMD-level decision makers when evaluating a RAPID MCM for potential administration to US warfighters; and JPEO- and CBDP-level decision makers when determining portfolio investment strategies or rapid response adjustments based on changing circumstances. \nThis Industry Day will include presentation by JPL EB as well as opportunities for industry partners to present their capabilities in one-on-one breakout sessions with representatives from the Government agencies. Industry partners will update Government stakeholders\, partners\, and end users on current efforts and capabilities. \nCompanies that wish to attend must register no later than 19 Feb 2024. More information is available at SAM.gov Notice ID W911SR-24-S-RAPID.
URL:https://globalbiodefense.com/event/medical-countermeasures-rapid-access-to-products-in-development-rapid-virtual-industry-day/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240224
DTEND;VALUE=DATE:20240229
DTSTAMP:20240202T041837Z
CREATED:20240202T041825Z
LAST-MODIFIED:20240202T041837Z
UID:59826-1708732800-1709164799@globalbiodefense.com
SUMMARY:Pittcon 2024
DESCRIPTION:Pittcon 2024 will be held 24-28 February 2024 in San Diego\, California. \nThis 75th edition of the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon) is for anyone who develops\, buys\, or sells laboratory equipment\, performs physical or chemical analyses\, develops analysis methods\, or manages these scientists. \nPittcon is a dynamic\, international conference and exposition on laboratory science\, a venue for presenting the latest advances in analytical research and scientific instrumentation\, and a platform for continuing education and science-enhancing opportunity. \nHighlighted agenda and short course topics include: \n\nPoint-of-use Raman spectroscopic characterization of pathogens\nThermally Robust Biomimetic Substitutes to Metalloenzymes for Rapid Hydrolytic Degradation and Electrochemical Field Detection of Chemical Warfare Agents\nStrategy and Instrumentation for Safety Protection of Personnel Working on Ships for Maritime Chemical Threat Assessment and Response\nChemical Spill and Chemical Fires in East Palestine\, Ohio: Chemical Fate and Exposure Pathways\nField-deployable Biosensors for Rapid Characterization of Microbiomes\nNuclear Forensics: Analytical Chemistry Combating Nuclear Terrorism\nLabel-Free Lab on a Chip Device for Purification and Characterization of Small Extracellular Vesicles\nFighting Bacteria with Micromotors\nTargeted and Untargeted Analysis for Rapid Response Following Disasters\nOvercoming Challenges in Pharmaceutical Development Using Novel Analytical Approaches\nApplication of 2DLC to novel therapeutics\nModified Membranes for Rapid Monoclonal Antibody Capture\, Digestion\, and Analysis\nBiomarker Detection using Microfluidics\nHandheld Near-Infrared Spectroscopy: Anywhere\, Anytime by Anybody\nIntroduction to Quantitative Spectroscopy for Near Infrared and Raman Instrumentation\nIntroduction to Solid State NPR Spectroscopy\nFundamentals and Recent Developments of X-Ray Photoelectron Spectroscopy\nThe Art of Structure Elucidation of Small Molecules Using Mass Spectrometry\nIndustrial Problem-Solving Using Surface FTIR Techniques\nEffective Technical Communication for Analytical Chemists\nMethod Translation and Modelling in Gas Chromatography\nThermal Gel Electrophoresis to Streamline Biological Characterizations\n\nPlease visit the Pittcon 2024 website for more information and to register to attend.
URL:https://globalbiodefense.com/event/pittcon-2024/
LOCATION:San Diego Convention Center\, 111 West Harbor Drive\, San Diego\, CA 92101\, 92101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240224T190000
DTEND;TZID=America/New_York:20240224T213000
DTSTAMP:20240202T001437Z
CREATED:20240202T001437Z
LAST-MODIFIED:20240202T001437Z
UID:59824-1708801200-1708810200@globalbiodefense.com
SUMMARY:An Enemy of the People: A Public Health Project
DESCRIPTION:LabX – a program of the National Academy of Sciences – in partnership with Cultural Programs of the NAS\, present An Enemy of the People\, featuring performances by acclaimed actors David Strathairn (Nomadland)\, Keith David (Nope)\, Brían F. O’Byrne (The Wonder)\, and Jay O. Sanders (True Detective) as well as public health leaders Anthony Fauci (Former Director\, National Institute of Allergy and Infectious Diseases)\, Francis Collins (Former Director\, National Institutes of Health)\, Keshia Pollack Porter (Chair\, Department of Health Policy and Management\, Johns Hopkins Bloomberg School of Public Health)\, Gloria Addo-Ayensu (Director of Health\, Fairfax County Health Department)\, Ruth Faden (Founder\, Johns Hopkins Institute of Bioethics)\, Victor Dzau (President\, National Academy of Medicine)\, Nancy Kass (Deputy Director of Public Health at the Johns Hopkins Institute of Bioethics)\, Vivian Pinn (Senior Scientist Emerita at the NIH Fogarty International Center) and more! \nTogether they will perform dramatic readings of scenes from Henrik Ibsen’s 1882 play An Enemy of the People to help frame powerful\, guided audience discussions aimed at generating connection\, understanding\, compassion\, moral repair\, and much-needed healing. \nAn Enemy of the People tells the story of a doctor who discovers the water supply in his small\, rural town has been poisoned by a tannery. Despite his efforts to convey the truth to the public\, the doctor fails to save his community from environmental disaster and is ultimately scapegoated for his whistleblowing. An Enemy of the People was first performed in Norway in 1882\, and yet it speaks to the present moment as if it were written for our times — to the corrosive influence of power and money in politics\, the distortions of the media\, and the many other challenges to public health in our culture today\, especially during times of crisis. \nJoin NAS for an evening of profound exploration\, thought-provoking dialogue\, and shared intellectual engagement. \nPresented by Theater of War Productions and LabX – A Program of the National Academy of Sciences in partnership with Cultural Programs of the National Academy of Sciences. Adapted\, directed\, and facilitated by Bryan Doerries. \nPlease visit the National Academies’ An Enemy of the People: A Public Health Project to register to attend.
URL:https://globalbiodefense.com/event/an-enemy-of-the-people-a-public-health-project/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240228
DTEND;VALUE=DATE:20240301
DTSTAMP:20240226T215053Z
CREATED:20240226T215042Z
LAST-MODIFIED:20240226T215053Z
UID:60125-1709078400-1709251199@globalbiodefense.com
SUMMARY:Meeting of the Advisory Committee on Immunization Practices (ACIP)
DESCRIPTION:The CDC’s Advisory Committee on Immunization Practices (ACIP) will convene 28-29 February 2024 in Atlanta\, GA and via webcast. \nThe ACIP develops recommendations for U.S. immunizations\, including ages when vaccines should be given\, number of doses\, time between doses\, and precautions and contraindications. \nThe agenda will include the following: \n\nUpdate on chikungunya vaccine licensure and review of proposed policy options for chikungunya vaccine use among U.S. adults traveling abroad\, laboratory workers\, and pregnant and breastfeeding persons\nGuidance to use Td vaccine for those instances when receipt of the pertussis component is contraindicated\nCOVID-19 vaccination coverage\, effectiveness and economic analysis of additional dose recommendations\nNext steps for the COVID-19 vaccine program\nInterim estimates of 2023-24 seasonal influenza vaccine effectiveness\nSafety of LAIV4 in children with asthma\nInfluenza B/Yamagata update\nPolio Work Group deliberations on potential use of nOPV2 as an outbreak control measure in the US\nClinical considerations for children who received fractional dose inactivated polio vaccine (fIPV) in other countries\nPost-marketing safety surveillance of older adult RSV vaccination\nPreliminary Analysis of Guillain-Barré Syndrome (GBS) following RSV vaccination among adults 65 years and older\nOverview of Moderna’s investigational RSV Vaccine (mRNA-1345) in adults ≥60 years of age\nRevising the adolescent Meningococcal vaccine schedule\nCurrent epidemiology of invasive pneumococcal disease and pneumococcal vaccine coverage in adults\nPreliminary findings of the Pneumococcal pNeumonia Epidemiology\, Urine serotyping\, and Mental Outcomes (PNEUMO) US study\nBackground on invasive Hib disease and vaccination among American Indian and Alaska Native Populations\n\nThe meeting will be held on February 28\, 2024\, from 8 a.m. to 5 p.m.\, EST and February 29\, 2024\, from 8 a.m.\nto 3 p.m.\, EST (times subject to change). \nPlease visit the CDC’s Advisory Committee on Immunization Practices for the latest information. No registration is required to watch the webcasts.
URL:https://globalbiodefense.com/event/meeting-of-the-advisory-committee-on-immunization-practices-acip/
LOCATION:https://video.ibm.com/channel/VWBXKBR8af4
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240304
DTEND;VALUE=DATE:20240306
DTSTAMP:20240201T221507Z
CREATED:20240201T221507Z
LAST-MODIFIED:20240201T221507Z
UID:59820-1709510400-1709683199@globalbiodefense.com
SUMMARY:Assessing the Burden and Potential Strategies to Address Antimicrobial Resistance
DESCRIPTION:A National Academies’ committee of experts will convene 4-5 March 2024 for a workshop to discuss the burden of antimicrobial resistance and strategies to address AMR challenges. \nParticipants can attend the workshop virtually and submit questions to speakers. The event will take place 12:00 PM – 4:15 PM ET each day. \nThere is broad recognition of the critical need to address the development and spread of antimicrobial resistance (AMR). A global\, systematic analysis estimates that AMR infections lead to 1.27-4.95 million deaths per year\, and resistant bacterial infections are now a leading cause of neonatal mortality worldwide. While scientific and economic challenges have long hindered development of novel antimicrobials\, recent pull incentives have been proposed to support a sustainable market and investment in new antimicrobials. These recent discussions provide a timely opportunity to explore the current burden of AMR and discuss potential future policies in the context of new scientific innovations. \nHighlighted agenda topics include: \nMonitoring AMR in Plants\, Animals\, and the Environment \n\nModerator: Ramanan Laxminarayan\, One Health Trust\nEnvironmental and Wastewater Surveillance: Joakim Larsson\, University of Gothenburg\nAMR in Livestock and Food Systems (or Crops): Paul Plummer\, Iowa State University College of Veterinary Medicine\nRole of AMR in Cross-cutting Conferences – Experience from COP28: Haileyesus Getahun\, World Health Organization\n\nMaking Meaning from Metrics: What’s at Stake? \n\nModerator: Chris Braden\, U.S. Centers for Disease Control and Prevention\nImpact of AMR – what’s not being captured: Dawn Sievert\, U.S. Centers for Disease Control and Prevention\nModeling Prevention Strategies: Joseph Lewnard\, University of California\, Berkeley\n\nImpact of AMR Across Medical Practice \n\nModerator: Helen Boucher\, Tufts University\nSkilled Nursing Facilities: Susan Huang\, University of California\, Irvine\nSurgery: Shawn Rangel\, Boston Children’s Hospital\nOncology: John Wingard\, University of Flo\n\nStewardship \n\nOutpatient or Telemedicine Perspective: Kristin Ray\, UPMC Children’s Hospital of Pittsburgh\nAdvanced Diagnostics: Robin Patel\, Mayo Clinic\nPediatric Antimicrobial Stewardship (Hospital Perspective): Ritu Banerjee\, Vanderbilt University Medical Center\n\nAccess \n\nProtecting Pharmaceutical Supply Chains in LMICs: Anthony McDonnell\, Center for Global Development\nImproving Access and Balancing Stewardship in LMICs: Jennifer Cohn\, Global Antibiotic Research & Development Partnership\nSustainable Use of Available Medicines: Esmita Charani\, University of Cape Town\n\nInnovation \n\nSynthetic Biology and Artificial Intelligence: James Collins\, Massachusetts Institute of Technology\nConsiderations for Successful Public-Private Partnership Model in Antibiotic Development: Ken Duncan\, Bill & Melinda Gates Foundation\nSupporting New Antimicrobials in Clinical Use: Ramy Elshaboury\, Massachusetts General Hospital\n\nPlease visit NASEM’s Assessing the Burden and Potential Strategies to Address Antimicrobial Resistance: A Workshop for more information. \n 
URL:https://globalbiodefense.com/event/assessing-the-burden-and-potential-strategies-to-address-antimicrobial-resistance/
LOCATION:https://www.nationalacademies.org/event/41831_03-2024_assessing-the-burden-and-potential-strategies-to-address-antimicrobial-resistance-a-workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240304
DTEND;VALUE=DATE:20240306
DTSTAMP:20240301T192959Z
CREATED:20240301T192959Z
LAST-MODIFIED:20240301T192959Z
UID:60470-1709510400-1709683199@globalbiodefense.com
SUMMARY:25th Meeting of the Malaria Policy Advisory Group (MPAG)
DESCRIPTION:The open sessions of the WHO’s 25th meeting of the Malaria Policy Advisory Group (MPAG) will take place in Yaoundé\, Cameroon on 4–5 March 2024. Technical partners\, UN agencies\, and other members of the global malaria community are welcome to register for online participation only. \nHighlighted agenda items include: \n\nUpdate on malaria vaccines\nUpdate on subnational tailoring of malaria interventions and strategies\nGuiding principles for prioritizing malaria interventions in resource-constrained country contexts to achieve maximum impact (draft document) + summary overview\nBiological threats to malaria vector interventions\nUpdate on Gavi supported malaria learning agenda\nGuiding principles for prioritization overview\nStrategy to respond to antimalarial drug resistance in Africa – updates and identification of needs\nUpdate on development of guidelines recommendations on tafenoquine\, primaquine and near-patient G6PD diagnostic test to support radical cure of P. vivax\nUpdate on malaria elimination\, including zoonotic malaria\n\nPlease visit the WHO’s Malaria Policy Advisory Group Meeting webpage to register.
URL:https://globalbiodefense.com/event/25th-meeting-of-the-malaria-policy-advisory-group-mpag/
LOCATION:Yaoundé\, Cameroon\, Yaoundé\, Cameroon
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240306
DTEND;VALUE=DATE:20240309
DTSTAMP:20240301T194704Z
CREATED:20240301T194529Z
LAST-MODIFIED:20240301T194704Z
UID:60473-1709683200-1709942399@globalbiodefense.com
SUMMARY:2024 St. Jude-PIDS Pediatric Infectious Diseases Research Conference
DESCRIPTION:The 23rd annual St. Jude-PIDS Pediatric Infectious Diseases Research Conference will be March 6-8\, 2024 in Memphis\, TN and virtually. \nHighlighted agenda items include: \n\nDengue: From Local Risk to Global Epidemics\nA Journey in Dengue Vaccine Research\nA Renaissance of Novel Antifungal Agents: Learning from Expanded Use in Pediatric Patients\nA One Health Approach to Antibiotic Resistant Gram-Negative Bacteria in the Community\nWhat’s New and on the Horizon for Pneumococcal and RSV Vaccines in Children\n\nPlease visit the St. Jude-PIDS Pediatric Infectious Diseases Research Conference event website for more information and to register for the conference.
URL:https://globalbiodefense.com/event/2024-st-jude-pids-pediatric-infectious-diseases-research-conference/
LOCATION:The Peabody Memphis\, 149 Union Ave\, Memphis\, TN\, 38103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T080000
DTEND;TZID=America/New_York:20240306T090000
DTSTAMP:20240301T202233Z
CREATED:20240301T202233Z
LAST-MODIFIED:20240301T202233Z
UID:60478-1709712000-1709715600@globalbiodefense.com
SUMMARY:Lessons on Urban Mass Drug Administration Towards Elimination of Neglected Tropical Diseases
DESCRIPTION:This session will provide examples of innovative strategies that have been used to tailor and strengthen mass drug administration in urban contexts for the control and elimination of neglected tropical diseases. \nA group of diverse speakers will highlight the latest implementation experience on promising practices and approaches that can be applied to varied urban contexts. Session participants will help specify and prioritize operational research gaps for urban MDA. \nSpeakers: \n\nDr. Jonathan King\, WHO\nProfessor Benjamin Koudou\, CSRS\nDr. Muhammad Babar Khan\, RTI International\nMarie Maud Jean\, WI-HER\nRajshree Das\, PCI India\n\nOrganized by COR-NTD\, Act to End NTDs East\, USAID and RTI International
URL:https://globalbiodefense.com/event/lessons-on-urban-mass-drug-administration-towards-elimination-of-neglected-tropical-diseases/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T140000
DTEND;TZID=America/New_York:20240306T150000
DTSTAMP:20240301T223634Z
CREATED:20240301T223634Z
LAST-MODIFIED:20240301T223634Z
UID:60493-1709733600-1709737200@globalbiodefense.com
SUMMARY:NACCHO Presents: Long COVID Overview with CDC
DESCRIPTION:Please join NACCHO and CDC for a presentation on long COVID featuring Priti Patel\, MD\, MPH\, and Sharon Saydah\, PhD\, MHS\, from CDC’s National Center for Immunization and Respiratory Diseases. \nThe webinar will provide an overview of long COVID\, explore existing research\, and include time for a Q&A. \nInitial questions for the Q&A may be submitted when registering.
URL:https://globalbiodefense.com/event/naccho-presents-long-covid-overview-with-cdc/
LOCATION:https://naccho.zoom.us/webinar/register/WN_GmQhefy3SaqaW_xses1ieg#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240307
DTEND;VALUE=DATE:20240311
DTSTAMP:20240111T184249Z
CREATED:20240111T180627Z
LAST-MODIFIED:20240111T184249Z
UID:59600-1709769600-1710115199@globalbiodefense.com
SUMMARY:CUGH 2024 - Consortium of Universities for Global Health
DESCRIPTION:The Consortium of Universities for Global Health will convene the CUGH 2024 Conference on 7 March 2024 in Los Angeles\, CA and via satellite sessions. \nFree and Open to the public Satellite Sessions begin at 8:00am on March 7\, 2024. Conference will begin at 4:30pm on March 7\, 2024. \nHighlighted agenda items include: \nDecolonizing the Pandemic Fund: Charting an Equitable Path Forward \nRobust and equitable financing for pandemic prevention\, preparedness\, response\, and reconstruction (PPPRR) is essential to prevent global health crises like COVID-19. The World Bank launched the Pandemic Fund to address this. Yet\, the Fund grapples with acquiring sufficient capital for PPPRR in low—middle— income countries and addressing policies that limit transparent and efficient fund allocation. For this panel\, we’ll gather health financing specialists\, including a Pandemic Fund board member from the Global South’s civil society. We’ll discuss how civil society can improve the Pandemic Fund’s transparency\, promote efficient fund distribution\, and enhance implementation effectiveness. In an era where donors demand fund accountability and recipient countries desire freedom from colonialist oversight mechanisms\, civil society’s role is crucial. This engagement is key to redefining and decolonizing global health financing accountability\, positioning it within the country with independent institutions. \nThe Rise of Anti-Science Disinformation and its Impact on Global Public Health \nThe rise of anti-science disinformation and its impact on global public health discusses the rise of targeted attacks against biomedical science and scientists\, especially in the areas of vaccinology and virology\, and how this will block global efforts at pandemic preparedness. How to overcome this through a combined approach of improved public health communications + directly combating sources of disinformation \nBuilding a Resilient Global Health Workforce: Training for the challenges ahead \nThe global health workforce faces unprecedented challenges\, from pandemics to evolving healthcare needs in a rapidly changing world. To address these challenges\, there is a pressing need to train a diverse and adaptable pool of health workers capable of meeting the demands of the future. This abstract introduces a panel which explores innovative approaches to prepare healthcare professionals for the complexities of modern healthcare delivery. Global health systems are strained by factors such as demographic shifts\, emerging diseases\, and health inequalities. To bridge these gaps\, transformative solutions are required. Training a diverse cadre of health workers is central to meeting this need and building resilience in health systems. This panel aims to spark a conversation on the vital role of training in building a resilient global health workforce that can effectively tackle the multifaceted challenges facing healthcare systems worldwide. \nStrengthening Global Health Security: Building bridges between civilians and the military \nThis panel aims to provide global health professionals at all levels with a comprehensive understanding of the pivotal role played by the defense and security sectors in Global Health Security (GHS). As health crises transcend borders and have impacts far beyond health\, it’s essential to grasp the nuanced contributions and considerations of these sectors within the evolving multilateralGHS framework. Our panelists will adeptly contextualize the capabilities and constraints of these sectors\, explore how civil-military collaboration in GHS is not merely reactionary but proactive\, and describe multifaceted strategies to ensure cohesive and effective multisectoral approaches to safeguarding global health. \n Leveraging Digital Learning in Health Emergencies for Health Equity \nIn the evolving landscape of health emergencies\, a system that rapidly equips frontline health workers with the necessary information and skills can significantly improve outcomes and save lives. Digital learning presents a unique opportunity to transcend geographic\, financial\, and political barriers to do just that. This panel discussion delves into the transformative potential of just-in-time digital learning in enhancing emergency preparedness and response to public health crises. Representatives from the World Health Organization (WHO) will share insights into global initiatives and the importance of standardized\, yet adaptable\, digital learning modules. Project ECHO\, an evidence-based telementoring initiative that leverages videoconferencing to connect specialists with the broader health workforce in real-time discussion\, epitomizes this potential of adaptable digital platforms. ECHO experts\, including representatives from Seed Global Health\, University of Nebraska Medical Center\, and University of Botswana\, will share how they leveraged the case-based ECHO learning model to rapidly engage thousands of frontline health workers in collaborative problem solving during the 2023 Sudan conflict\, Ukraine war\, 2022 Ebola outbreak\, and COVID-19 pandemic. Converging the perspectives of both WHO and Project ECHO\, this panel aims to create dialogue on the present capabilities and future potential of digital learning in bolstering public health resilience globally. \n Training the Next Generation of Global Health Researchers \nThe Fogarty Global Health Fellows and Scholars Program\, established in 2004\, has provided support to over 1\,600 trainees from the United States and Low- and Middle-Income Countries (LMICs). Seven consortia of U.S. academic institutions collaborate to offer these fellowships\, facilitating mentored research training in LMIC partner institutions. Research within the program spans diverse global health topics\, encompassing communicable diseases like HIV/AIDS\, non-communicable diseases\, mental health\, and more. In a 90-minute panel discussion\, program trainees will share insights into their research\, training experiences\, and career paths. The Fogarty International Center’s leadership will also reflect on the program’s impact and achievements. This discussion will unite distinguished alumni and current trainees of the NIH-Fogarty Global Health Program\, showcasing individuals with varying backgrounds\, including U.S. and international trainees\, MD and PhD fellows\, and representing different career stages. \nDiagnostic Testing and Imaging Services in Low- and Middle-Income Countries: Addressing supply chain and policy bottlenecks for equitable access \nWithin the realm of modern medicine\, appropriate diagnostic capacity is indispensable in guiding treatment. Nonetheless\, diagnostics and imaging technology\, in contrast to pharmaceuticals and vaccinations\, are often relegated to the periphery. Nowhere is the problem more acute than in low-and middle-income countries (LMICs). Despite recent investments directed towards enhancing health diagnostics and imaging\, their latent potential to confer substantial benefits and improved patient outcomes remains unrealized. LMICs must confront challenging and often inequitable supply-chain practices and an international\, geopolitical landscape with competing political agendas. This panel session will directly address the myriad of issues preventing equitable access to quality diagnostic testing and imaging services in LMICs. \nClimate Change as a Threat to Global Health & Human Rights \nThe inequitable health threats of climate change pose sweeping implications for health-related human rights\, especially in low- and middle-income countries\, with environmental degradation challenging the most fundamental conditions for human life and the individual dignity and rights of vulnerable populations and future generations. However\, international negotiations to mitigate emissions — from the 1992 United Nations Framework Convention on Climate Change and its 1997 Kyoto Protocol to the 2015 Paris Agreement — have realized limited success in addressing the health hazards caused by the unfolding climate crisis. This session frames the rapidly evolving state of discourse on public health and human rights in climate change debates — examining global governance efforts\, academic research\, NGO advocacy\, and youth engagement. This session addresses the synergies between global health\, human rights\, and climate justice\, with a focus on understanding the global health threats of anthropogenic climate change and identifying the human rights advancements necessary to frame international law reforms for mitigation and adaptation. \nHost institutions for CUGH 2024 are the National Cancer Institute (NCI)\, UCSF Institute for Global Health Sciences\, UW Department of Global Health\, and the USC Insitute on Inequalities in Global Health. \nPlease visit CUGH 2024 to register.
URL:https://globalbiodefense.com/event/cugh-2024-consortium-of-universities-for-global-health/
LOCATION:Westin Bonaventure Hotel and Suites\, 404 S Figueroa St\, Los Angeles\, California\, 90071\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240307T120000
DTEND;TZID=America/New_York:20240307T130000
DTSTAMP:20240301T203718Z
CREATED:20240301T203718Z
LAST-MODIFIED:20240301T203718Z
UID:60481-1709812800-1709816400@globalbiodefense.com
SUMMARY:Indoor Air and Infectious Disease Transmission
DESCRIPTION:The Institute for Pandemics (IfP) in collaboration with the Canadian Public Health Association presents a webinar for public health professionals to hear the latest research on indoor air transmission of infectious diseases and strategies to reduce exposure. \nThis webinar is a preview to the symposium\, “Something in the air: Towards a new understanding of aerosols and respiratory disease transmission”\, that will be presented at Public Health 2024 in Halifax this April. \nDr. Raymond Tellier will introduce the concept and definition of respiratory bioaerosols\, and review some of the abundant scientific evidence supporting an important role for aerosol transmission of influenza A virus and SARs-CoV-2 virus\, 2 agents with a proven pandemic capacity. \nDr. Sarah Haines will present her recent work on portable air cleaners to detect SARs-CoV-2 as well as identifying ventilation and other strategies that may be beneficial in reducing viral exposure. \nPlease visit the University of Toronto Institute for Pandemics’ Indoor Air and Infectious Disease Transmission event page to register.
URL:https://globalbiodefense.com/event/indoor-air-and-infectious-disease-transmission/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240310
DTEND;VALUE=DATE:20240315
DTSTAMP:20240112T174003Z
CREATED:20240112T174003Z
LAST-MODIFIED:20240112T174003Z
UID:59619-1710028800-1710460799@globalbiodefense.com
SUMMARY:CDC International Symposium on Biosafety 2024
DESCRIPTION:The 18th CDC International Symposium on Biosafety – Modernizing Biosafety Operations and Practices – will be held 10-14 March 2024 in Atlanta\, Georgia. \nThe symposium offers a showcase of the latest advancements in biosafety research\, interactive workshops to gain practical insights on applications\, expert insight on design and operation of biocontainment and animal facilities\, and behind-the-scene tours of the Emory Primate Center Field Research Station and CDC’s Emergency Operations Center Laboratory Training Facility. \nHighlighted conference topics and sessions include: \n\nModern Lab Design: A Success Story\nQuestions to Consider When Designing ABSL-3 Facilities\nABSL-3 Case Study\nImplementing ISO 35001\nWaste Management in Animal Facilities\nLatest in Biosafety Research\nPanel: Hiring\, Retention\, Worker Shortage\nAI’s Role in Biosafety Training\nSpaceflight Microbiology: Mitigating Health and Habitat Risks While Living and Working in Space\nPathogens of the Future\n\nPre-conference classes will be offered for all levels: \n\nBiosafety 101\nEstablishing Biosafety Levels in the Field\nReviewing Past Exposures to Improve Biosafety\nNavigating the Integration of Biosafety\, Biosecurity\, and Emergency Management\nRisky Business: Animal Biosafety Assessments\n\nPoster Abstracts are being accepted until 15 February 2024. \nPlease visit the Eagleson Institute’s CDC International Symposium on Biosafety page to register for this event.
URL:https://globalbiodefense.com/event/cdc-international-symposium-on-biosafety-2024/
LOCATION:Crown Plaza Ravinia\, 4355 Ashford Dunwoody Rd\, Atlanta\, GA\, 30346\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240310
DTEND;VALUE=DATE:20240315
DTSTAMP:20240301T213559Z
CREATED:20240301T213315Z
LAST-MODIFIED:20240301T213559Z
UID:60484-1710028800-1710460799@globalbiodefense.com
SUMMARY:SOT 2024 - Society of Toxicology Annual Meeting
DESCRIPTION:The 2024 Annual Meeting of the Society of Toxicology will gather more than 5\,000 toxicologists and related stakeholders for five days of Featured and Scientific Sessions\, 2000+ poster presentations\, networking events\, and the popular three-day ToxExpo. \nHighlighted session topics include: \n\nUpdate on the Development of Medical Countermeasures and Biomarkers against Pulmonary Chemical Threat Agents\nApproaches for Treatment of Nerve Agent Poisoning: From Experimental Laboratories to Intensive Care Units\nPhosgene Inhalation Injuries: Potential Medical Countermeasures and Biomarkers\nThe Göttingen Minipig for Medical Countermeasures Development: Benefits and Capabilities\nNix the Six: Strategies for Implementing Nonanimal Acute Toxicity Testing\nA Strategic Approach to Nonclinical Anti-Drug Antibody Assessment\nThe Evolution of BioTech into TechBio\nHigh-Throughput In Vitro—In Vivo Extrapolation for Predictive Toxicology\nEvaluation of Drug-Induced Liver Toxicity of Trovafloxacin in a Human Microphysiological Liver Model\nFoundations of Embryonic and Fetal Development and Application to Developmental Toxicity Testing\n‘Relax Immune System\,’ Cell and Gene Therapy Here\nPreclinical Development of RNA-Editing\, Gene\, and Cell Therapies: Risks and Challenges\nHepatoPRIME: Primary Human Hepatocytes for Superior Toxicology Assay Outcomes\nWeight of Evidence Analysis and Problem Formulation for Chemical Risk Assessment: Fundamental Principles and Application through Case Examples\nBenchmark Dose Modeling and Its Applications in Drug\, Food\, and Chemical Safety Evaluation and Assessment\nFeasibility Study of Long-Term Repeated Intracerebroventricular Administration in Cynomolgus Monkeys\nAI Will Only Replace Toxicologists Who Do Not Use It\nVariation in Seroprevalence of Adeno Associated Viruses (AAVs) Serotypes in Non-Human Primates (NHPs)\nBridge over Adverse Waters: Integrating Pathology Findings into the Interpretation of Toxicology Studies\nHarnessing Toxicology in Pregnancy: Traditional and Novel Approaches to Placental Toxicology Research\nPutting Theory into Practice: Using Computational New Approach Methodologies in Next-Generation Risk Assessment\nUse of New Approach Methodologies for the Assessment of Inhaled Substances: Examples and Case Studies\nNeurotoxicity and Neuroinflammation Profiles in Animal Models\nSerial Blood Sampling and Comparison of Three 91-day Continuous Intravenous Infusion Models in the Rat in Safety Assessment Studies\nA Current Prevalence Study for Laboratory Rodent Adventitious Infectious Agents\n\nPlease visit the SOT 2024 Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/sot-2024-society-of-toxicology-annual-meeting/
LOCATION:Salt Palace Convention Center\, 100 S W Temple St\, Salt Lake City\, UT\, 84101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240314
DTSTAMP:20240306T201823Z
CREATED:20240306T201823Z
LAST-MODIFIED:20240306T201823Z
UID:60520-1710201600-1710374399@globalbiodefense.com
SUMMARY:Resilient and Scalable MCM Ecosystem: WHO Coordination Meeting for Advancing Timely and Equitable Access
DESCRIPTION:The World Health Organization is convening representatives from regional entities on 12 – 13 March 2024 for an in-person meeting for a Resilient and Scalable MCM Ecosystem: Regional Entities Coordination Meeting for Advancing Timely and Equitable Access to Medical Countermeasures Against Pandemic Threats. \nThe impact of the COVID-19 pandemic highlighted collective vulnerabilities and the need to strengthen the international community’s preparedness to future pandemics. \nThe WHO-led interim coordination mechanism aims to enhance collaboration for timely and equitable access to medical countermeasures (MCM) against pandemic threats\, through a network-of-networks approach (i-MCM-Net) by leveraging existing networks in the global MCM ecosystem\, without prejudging or precluding INB and IHR discussions\, while awaiting the finalization of the INB deliberations. \nThe current focus of the i-MCM-Net is to understand how ready the world is in terms of equitable access to MCMs\, should a new pandemic threat emerge. Including to identify gaps and potential priority actions to improve readiness. \nWith a view to enhance coherence and foster synergies\, this meeting will provide an opportunity for the i-MCM-Net to provide an update on the analysis underway around Pandemic Influenza\, Novel Coronavirus and Disease X and to hear insights and perspectives on the analysis. \nExpected outcomes:\n\nEstablish cross-regional level communication channels and start an ongoing conversation among regional entities to improve collaboration for timely and fair access to MCM against pandemics.\nContribute input and feedback on the initial mapping of MCM (the i-MCM-Net mapping report)\, which will be further refined by May 2024.\nProvide input for a practical framework ensuring informed procedures for developing\, producing\, accessing\, allocating\, and deploying MCMs against pandemic threats.\n\nPlease visit the WHO’s Resilient and Scalable MCM Ecosystem: Regional Entities Coordination Meeting for Advancing Timely and Equitable Access to Medical Countermeasures Against Pandemic Threats website for more information.
URL:https://globalbiodefense.com/event/resilient-and-scalable-mcm-ecosystem-who-coordination-meeting-for-advancing-timely-and-equitable-access/
LOCATION:WHO Headquarters\, Geneva\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240318
DTSTAMP:20240106T184627Z
CREATED:20230422T184308Z
LAST-MODIFIED:20240106T184627Z
UID:57065-1710201600-1710719999@globalbiodefense.com
SUMMARY:2024 Fungal Genetics Conference
DESCRIPTION:The 2024 Fungal Genetics Conference\, the premier meeting for fungal genetics researchers\, will be held 12-17 March 2024 in Pacific Grove\, California \nThe Fungal Genetics Conference is the premier meeting for the international community of fungal geneticists. The conference features cutting-edge research spanning a diverse array of topics\, including comparative and functional genomics\, gene regulation\, cell biology\, biochemistry and metabolism\, population and evolutionary genetics\, host-pathogen interactions\, genetics education\, and more. \nThis is considered by many to be the pre-eminent meeting in this area and promotes interaction between researchers interested in medical pathogens\, plant pathogens\, saprobic fungi and symbiotic fungi. \n\nHighlighted topics and sessions include:\nFunctional genomics illuminates foundational biology and evolution\nNew technologies to understand and control antifungal resistance\nMultilevel regulatory circuits to understand fungal metabolism\nUnderneath\, within\, and around: pathogens and symbionts\nGenetic control of primary and secondary metabolism\nFungi at the cutting edge – microfluidics and other new tools\nMachine Learning in Fungal Genetics\nExperimental evolution with fungi\nInteractions of fungi with the biosphere\nMorphogenesis at multiple scales\nHorizontal gene transfer\, meiotic drive\, and related phenomena\nBiofilms\, biocontrol\, and disease prevention by genome engineering\nUnderstanding fungal pathogenesis by genomics\nSignaling in the gas phase\nPhase separation and sequestration\n\nA virtual attendance option is planned in addition to the in-person meeting. Virtual participant registration fees for full-time residents of any country with low- and middle-income economies will be waived. \nPlease visit the Genetics Society of America 2024 Fungal Genetics Conference website for more the latest information and to register.
URL:https://globalbiodefense.com/event/2024-fungal-genetics-conference/
LOCATION:Asilomar Conference Grounds\, 800 Asilomar Ave\, Pacific Grove\, CA\, 93950\, United States
CATEGORIES:Conference
ORGANIZER;CN="Genetics Society of America":MAILTO:society@genetics-gsa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240313
DTEND;VALUE=DATE:20240316
DTSTAMP:20240306T223831Z
CREATED:20240306T221528Z
LAST-MODIFIED:20240306T223831Z
UID:60523-1710288000-1710547199@globalbiodefense.com
SUMMARY:Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies
DESCRIPTION:Wellcome Genome Campus will host Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies on 13-15 March 2024 in Hinxton\, UK with onsite or virtual attendance. \nThis year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for antimicrobial resistance (AMR) control. The meeting will highlight the advances in machine learning\, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues. \nAMR is a major challenge in our globalised world\, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens\, and a wealth of data is being collected in epidemiological and surveillance studies\, including on the socio-economic burden of AMR. \nDiscussions will focus on a variety of exciting topics\, including: \n\nGenomic surveillance of priority pathogens\nGlobal public health pathogen genomics infrastructure\nTranslation and implementation of genomics for AMR control\nWastewater surveillance\nAI\, machine learning\, and big data tools\nMeasuring the burden of AMR\n\nPlease visit the Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies event page for more information.
URL:https://globalbiodefense.com/event/antimicrobial-resistance-genomes-big-data-and-emerging-technologies/
LOCATION:Wellcome Genome Campus\, Hinxton\, CB10 1SA\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T090000
DTEND;TZID=America/New_York:20240313T100000
DTSTAMP:20240306T193945Z
CREATED:20240306T193721Z
LAST-MODIFIED:20240306T193945Z
UID:60515-1710320400-1710324000@globalbiodefense.com
SUMMARY:FMD Vaccine Availability in Africa and Prospects for Improved FMD Control
DESCRIPTION:Join the Global Foot-and-Mouth Disease Research Alliance (GFRA) for their Research Webinar series with Professor Baptise Dungu on 13 March 2024. \nProfessor Dungu will present on the status of FMD vaccine availability in Africa and prospects for improved FMD control through vaccination. \nThis 1-hour webinar will feature Professor Dungu’s 30-minute presentation followed by a 30-minute moderated Q&A session. \nThis series of research webinars presented by the GFRA is inspired by our networking philosophy. This online event series contributes to the continuous professional development of stakeholders at the cutting edge of new ideas and developments in Foot-and-Mouth Disease research. \nThere is no charge for this webinar but registration is required.
URL:https://globalbiodefense.com/event/fmd-vaccine-availability-in-africa-and-prospects-for-improved-fmd-control/
LOCATION:https://crdfglobal.zoom.us/webinar/register/WN_utw1EgMLQFWO5nOgnLP6RQ#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240314T120000
DTEND;TZID=America/New_York:20240314T130000
DTSTAMP:20240214T233849Z
CREATED:20240214T190847Z
LAST-MODIFIED:20240214T233849Z
UID:59970-1710417600-1710421200@globalbiodefense.com
SUMMARY:GMU Schar School Master of Biodefense Information Session
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will be hosting a Master of Biodefense Information Session on Thursday\, March 14\, noon to 1:00 p.m. ET (Virtual). \nProspective students are invited to attend to hear more about the Master of Biodefense program offered at the Schar School of Policy and Government at George Mason University. \nLearn more about the program\, application process\, student experience\, and graduate outcomes. The program is offered in part-time\, full-time\, online\, in-person\, and hybrid formats. \n Learn more and register for the information session. \nGlobal Biodefense is an official media partner of the GMU Schar School of Policy and Government.
URL:https://globalbiodefense.com/event/gmu-schar-school-master-of-biodefense-information-session/
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/gmu-schar-school-ms-biodefense-1200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240315T100000
DTEND;TZID=America/Los_Angeles:20240315T110000
DTSTAMP:20240301T221921Z
CREATED:20240301T221921Z
LAST-MODIFIED:20240301T221921Z
UID:60491-1710496800-1710500400@globalbiodefense.com
SUMMARY:Introduction to the 2024 Joint Commission Standards for Infection Control
DESCRIPTION:Beginning this summer\, hospitals looking to maintain or apply for accreditation from The Joint Commission—the nation’s oldest and largest standards-setting and accrediting body in health care—will have to adopt a new set of standards for high-consequence infectious diseases (HCID). \nJoin NETEC for an exploration of the new infection control requirements established by the Joint Commission\, the nation’s oldest and largest standards-setting and accrediting body in health care. Panelists will review key changes to the standards\, which will go into effect July 1\, 2024\, and identify strategies for implementation and compliance. Resources and tools will be shared to empower your organization to help prepare for the new standards by July 2024. \nThis webinar is for health care professionals who will implement and/or provide training on these new standards including\, quality improvement teams​\, emergency managers\, infection preventionists\, hospital epidemiologists\, educational specialists\, nurse educators\, and coordinators for physician education. \nThe webinar is free and open to all health care professionals\, especially quality improvement teams\, emergency managers\, infection preventionists\, hospital epidemiologists\, educational specialists\, nurse educators\, and coordinators for physician education. \nPlease visit NETEC’s Introduction to the 2024 Joint Commission Standards for Infection Control to register. \nNETEC is a collaborative effort of 13 U.S. Regional Emerging Special Pathogen Treatment Centers (RESPTCs) working together to enhance the capacity of the U.S. public health and health care systems to manage special pathogens safely and effectively. Visit the NETEC website to access a wide range of special pathogen resources\, request free readiness consulting and assessment\, or ask your questions related to special pathogens readiness\, response\, or patient care.
URL:https://globalbiodefense.com/event/introduction-to-the-2024-joint-commission-standards-for-infection-control/
LOCATION:MD
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240315T143000
DTEND;TZID=Europe/Paris:20240315T160000
DTSTAMP:20240306T225301Z
CREATED:20240306T223149Z
LAST-MODIFIED:20240306T225301Z
UID:60528-1710513000-1710518400@globalbiodefense.com
SUMMARY:COMBINE Webinar on Developing Target Product Profiles for Antibiotics
DESCRIPTION:The AMR Accelerator programme will host a COMBINE Webinar on Developing Target Product Profiles for Antibiotics on 15 March 2024. \nDecisions on disease targets and whether to aim for oral or intravenous administration of a new compound requires complex decisions\, involving the desires\, needs and expectations of patients\, healthcare organisations and regulators across the globe. \nDeveloping Target Product Profiles (TPP) is a challenge for antibiotics development. In this webinar\, speakers from CARB-X\, Evotec and GSK will discuss TPPs in relation to aims\, timing\, scope and flexibility. The discussion will discuss the need for TPPs across the development life-cycle: from drug discovery to clinical trials\, taking into account both clinical pathways\, the area of application and market considerations. \nPlease visit the COMBINE Webinar on Developing Target Product Profiles for Antibiotics event page for more information.
URL:https://globalbiodefense.com/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240317
DTEND;VALUE=DATE:20240323
DTSTAMP:20240306T224549Z
CREATED:20240306T224549Z
LAST-MODIFIED:20240306T224549Z
UID:60531-1710633600-1711151999@globalbiodefense.com
SUMMARY:Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis
DESCRIPTION:Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis will take place 17-22 March 2024 in Ventura\, CA. \nThe antibiotic resistance crisis is among us\, and with it\, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process\, from target validation and inhibitor optimization to clinical trial design and product commercialization\, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies. \nThe conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide\, concentrating on the latest developments in the field. \nHighlighted sessions include: \n\nDiscovering Mechanistically Novel Antibacterial Leads through Phenotypic Screening\nAntisense Antibiotics as Precision Therapeutics for Pseudomonas aeruginosa\nAddressing Antimicrobial Resistance in Clostridioides difficile: Clinical Implications and the Motivation for Novel Treatment Approaches\nBiasing Bacteriophage Behaviours\nAntibiotics Preorganized for Ribosomal Binding Overcome Antimicrobial Resistance\nHost Directed Therapy Against Mycobacterial Infections\nGARDP: Working Globally to Address the Antimicrobial Resistance Crisis\nBeta-lactamases and Skaters: Pairs and Singles\nDevelopment of Broad-Spectrum MBL Inhibitors\nSystems Chemical Biology Approach to Antibiotic Discovery\nMacrocyclic Peptides Disassemble the Periplasmic LPS Transport Bridge: New Approaches to Kill Multidrug-Resistant Gram-Negative Bacteria\nCracking Nature’s Recipes to Design Lipid-Targeting Antibiotics\nChallenges of Antibacterial Discovery\nGenerative Artificial Intelligence for Antibiotic Discovery\nMulti-Drug Resistant (MDR) Pathogens Are Driving the Need for New Novel Antibacterials\nReviving Natural Products Antibiotic Discovery\n\nPlease visit the Gordon Research Conference’s Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis website for more information.
URL:https://globalbiodefense.com/event/innovative-approaches-in-antibacterial-research-and-development-to-fight-the-antibiotic-resistance-crisis/
LOCATION:Ventura Beach Marriott\, 2055 Harbor Boulevard\, 2055 E Harbor Blvd\,\, CA\, 93001\, United States
END:VEVENT
END:VCALENDAR